Condition: Major Depressive Episode · ECT · Sponsor: Hôpital le Vinatier
Investigators will measure the variation of blood Metabolome through 1H NMR at several time points during the course of electroconvulsivetherapy in patients with a major depressive episode. Patients with a major depressive disorder or a bipolar disorder and a current major depressive episode will be included in this study. Investigators hypothesized that Metabolome could be a source to predict response during ECT and to help understanding underlying biological mechanisms.
This description comes directly from the study's public registry record.
COSTEMALE-LACOSTE Jean-François, PH · (0)4 37 91 54 95 · jean-francois.costemale-lacoste@ch-le-vinatier.fr
SARTELET Lydie · 0437915531 · lydie.sartelet@ch-le-vinatier.fr
Always discuss trial participation with your own doctor first.
| Centre Hospitalier le Vinatier | Bron, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05973643